N-(1-Benzylpyrrolidin-3-yl)-2-chloropropanamide hydrochloride

Catalog No. :
ACUKVC158
CAS No. :
1210664-95-1
Molecular Formula :
C14H20Cl2N2O
Molecular Weight :
303.23

IUPAC Name:N-(1-benzylpyrrolidin-3-yl)-2-chloropropanamide hydrochloride

N-(1-Benzylpyrrolidin-3-yl)-2-chloropropanamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$142.00Login to see priceInquiryInquiry
100mg95%$207.00Login to see priceInquiryInquiry
250mg95%$286.00Login to see priceInquiryInquiry
1g95%$675.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(1-Benzylpyrrolidin-3-yl)-2-chloropropanamide hydrochloride
IUPAC NameN-(1-benzylpyrrolidin-3-yl)-2-chloropropanamide hydrochloride
MDL No.MFCD13196249
Molecular FormulaC14H20Cl2N2O
Molecular Weight303.23
SMILESCC(Cl)C(NC1CN(CC2=CC=CC=C2)CC1)=O.[H]Cl
InChI KeyLLURXHUSSPPUHV-UHFFFAOYSA-N
SynonymN-(1-Benzylpyrrolidin-3-yl)-2-chloropropanamide Hydrochloride
CAS No.1210664-95-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACUKVC158 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTCDS369 route compound structure diagram
    ACTCDS36918471-40-4 In Stock
  4. Then
  5. ACUKVC158 route product structure diagram
    ACUKVC1581210664-95-1
Inquiry

2. ACUKVC158 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTCDS369 route compound structure diagram
    ACTCDS36918471-40-4 In Stock
  4. Then
  5. ACUKVC158 route product structure diagram
    ACUKVC1581210664-95-1
Inquiry

Comments (0)